FDA Warning letter - Conzip

Discussion in 'Vertical Pharmaceuticals' started by anonymous, Sep 6, 2017 at 11:46 PM.

Tags: Add Tags

  1. anonymous

    anonymous Guest

    What does their marketing, quality, RA departments do over there? First the OB Gold debacle, then the Adverse Reporting FDA warning and now this?????
     
  2. anonymous

    anonymous Guest

    Ha! they get huge bonuses every year too. Not the sales force. HA!
     
  3. anonymous

    anonymous Guest

    "The warning letter was addressed to Cipher as the NDA holder. The Company's licensing partner, Vertical Pharmaceuticals, LLC ("Vertical") holds the exclusive U.S. license to market, sell and distribute ConZip. As the exclusive commercial distributor of ConZip in the U.S., Vertical is responsible for preparing and approving all marketing and promotional materials.... Vertical has informed Cipher that it has taken immediate corrective actions, including ceasing distribution of the ConZip promotional material cited in the warning letter, preparing a plan to collect and destroy the material, and commencing a corrective action communication to healthcare professionals. "
    http://cipher.investorroom.com/2017-09-07-Cipher-Pharmaceuticals-Comments-on-FDA-Warning-Letter-for-ConZip-R-Tramadol